Last reviewed · How we verify
NCT04033835
Mentalization Based Treatment - Introductory (MBT-I) Group for Male Prisoners With Borderline and/or Antisocial Personality Disorder
NA trial testing Mentalization Based Treatment-Introductory in Borderline Personality Disorder (BPD) in 30 participants. Status unknown.
1 August 2021
Quick facts
| Lead sponsor | NHS Greater Glasgow and Clyde |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 30 |
| Start date | 1 August 2019 |
| Primary completion | 1 August 2021 |
| Estimated completion | 1 August 2021 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Mentalization Based Treatment-Introductory
- Treatment as usual
Conditions studied
- Borderline Personality Disorder (BPD) — all drugs for Borderline Personality Disorder (BPD) →
- Antisocial Personality Disorder (ASPD) — all drugs for Antisocial Personality Disorder (ASPD) →
Sponsor
NHS Greater Glasgow and Clyde — full company profile →
Who can join
18 and older, male only, with Borderline Personality Disorder (BPD) or Antisocial Personality Disorder (ASPD). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Established evidence base with MBT for treatment of Borderline Personality Disorder (BPD) and/or Antisocial Personality Disorder (ASPD). Demographic information of United Kingdom prison population highlights large proportion of offenders with PD. There is no agreed universal approach to treatment of PD within Scottish prisons with large variance across the prison estate. MBT pilots in HMP Edinburgh and HMP Cornton Vale have demonstrated positive findings in female offenders which could be replicated in male populations.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Psychological interventions for antisocial personality disorder.
Gibbon S, Khalifa NR, Cheung NH, Völlm BA, et al · · 2020 · cited 31× · PMID 32880104 · DOI 10.1002/14651858.cd007668.pub3
Verify or expand the search:
- PubMed search for NCT04033835
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Borderline Personality Disorder (BPD)
Currently open trials in the same condition.
- NCT07341438 — Physical Activity in the Management of Personality Disorders · NA · recruiting
- NCT06699732 — Impact of Mindful Self-Compassion Therapy on Self Harm Behaviors, Emotional Regulation and Quality of Life Among Patient · NA · recruiting
- NCT06195553 — Application and Effectiveness of the STEPPS in Patients with BPD, Extending to Their Families with the FC Program · NA · recruiting
Other NHS Greater Glasgow and Clyde trials
Trials by the same sponsor.
- NCT07403890 — Rewiring the Brain-Immune Axis for Chronic Pain Using Transcranial Magnetic Stimulation in Psoriatic Arthritis · NA · not yet recruiting
- NCT07372508 — Glasgow Low-dose CT and AI-based Diagnostics to Case Find Lung Cancer and Other Cardio-respiratory Long-term Conditions · NA · not yet recruiting
- NCT07391280 — Strategy for EArly Recognition of Cancer, COPD & Heart Failure in the Emergency Department · NA · not yet recruiting
- NCT07048184 — Sarcoma Surgery Wound Complications Comparing Usual Versus Negative Pressure Dressing · Phase 2 · not yet recruiting
- NCT06786936 — Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04033835 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NHS Greater Glasgow and Clyde
- Last refreshed: 26 July 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04033835.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing